Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00108_DB04572_nanopub.RAFDbUPCXd-DlKaiiFgnzAJt0ojbjYiYuw9CjG32rMLcA#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00108_DB04572 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00108_DB04572 label "DDI between Natalizumab and Thiotepa - The immunosuppressant, Thiotepa, may increase the adverse effects of Natalizumab. Increased risk of Progressive Multifocal Leukoencephalopathy (PML) and other infections. Concurrent therapy should be avoided. [drugbank_resource:DB00108_DB04572]" assertion.
- drugbank_resource:DB00108_DB04572 identifier "drugbank_resource:DB00108_DB04572" assertion.
- drugbank_resource:DB00108_DB04572 title "DDI between Natalizumab and Thiotepa - The immunosuppressant, Thiotepa, may increase the adverse effects of Natalizumab. Increased risk of Progressive Multifocal Leukoencephalopathy (PML) and other infections. Concurrent therapy should be avoided." assertion.
- drugbank:DB00108 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00108_DB04572 assertion.
- drugbank:DB04572 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00108_DB04572 assertion.